Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with decompensated chronic congestive heart failure, NYHA functional class III-IV, either ischemic or non-ischemic, requiring hospitalization, and with clinical indication for parenteral pharmacotherapy and invasive hemodynamic monitoring (i.e indwelling Swan-Ganz pulmonary artery catheter) and PCWP \>/= 18 mmHg.
Patients must have the clinical diagnosis of CHF made at least 3 month prior to enrollment.
Male or female patients, age 18 years or more.
You may not be if
Females of child-bearing potential.
Acute de-novo heart failure.
Acute myocardial infarction and/or myocardial infarction within 30 days.
Valvular heart disease requiring surgical intervention during the course of the study.
Clareo Health | Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667
